Neoadjuvant Encorafenib, Binimetinib and Cetuximab for Patients With BRAF V600E Mutated/pMMR Localized Colorectal Cancer

Clinical trial NCT05510895 · COMPLETED

Trial details

NCT number: NCT05510895
Sponsor: AIO-Studien-gGmbH
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Colorectal Cancer Colon Cancer BRAF V600E BRAF V600 Mutation Localized Cancer

Start date: 2022-09-01
Primary completion: 2024-07-31
Enrollment: 2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.